High-risk Genotypes
High-risk Genotypes - Related Videos
08:23
SNP Genotyping
0 Views •
2023
Single nucleotide polymorphisms, or SNPs, are the most common form of genetic variation in humans. These differences at individual bases in the DNA often do not directly affect gene expression, but in many cases can still be useful for locating disease-associated genes or for diagnosing patients. Numerous methodologies have been established to identify, or “genotype”, SNPs.JoVE’s introduction to SNP Genotyping begins by discussing what SNPs are and how they can be used to identify...
08:27
Mouse Genotyping
0 Views •
2023
Even though the human genome was mapped over 10 years ago, scientists are still far from understanding the function of every human gene! One way to evaluate how a gene functions is to disrupt the sequence encoding it and then evaluate the impact of this change (the phenotype) on the animal’s biology. This approach is commonly used in the mouse (Mus musculus), since it shares a high degree of genetic similarity with humans. To track the animals bearing genetic changes over several generations,...
11:00
Genotyping of Plant and Animal Samples without Prior DNA Purification
0 Views •
Cited by 14 •
2012
The Direct PCR approach presented here facilitates PCR amplification directly from small amounts of unpurified plant and animal tissue.
13:06
Pyrosequencing: A Simple Method for Accurate Genotyping
0 Views •
Cited by 22 •
2008
Pyrosequencing(R) is one of the most thorough yet simple methods to date used to analyze polymorphisms. This method has led to rapid and efficient single-nucleotide polymorphism evaluation including many clinically relevant polymorphisms. The technique and methodology of Pyrosequencing is explained.
13:33
Infinium Assay for Large-scale SNP Genotyping Applications
0 Views •
Cited by 15 •
2013
A protocol is described that uses Illumina's Infinium assays to perform large-scale genotyping. These assays can reliably genotype millions of SNPs across hundreds of individual DNA samples in three days. Once generated, these genotypes can be used to check for associations with a variety of different diseases or phenotypes.
FAQs
The central risk is persistence, not simply initial infection. When a high-risk genotype avoids immune clearance, prolonged exposure of infected tissue to viral activity increases the opportunity for damage and disease progression. This distinction helps immunologists connect pathogen variation with the host’s ability to eliminate infection and explains why persistent infection receives particular clinical and research attention.
Viral oncoproteins E6 and E7 provide a mechanistic link between genotype and abnormal cell regulation. In persistent infection, they disrupt tumor-suppressor pathways governed by p53 and retinoblastoma protein. Studying these interactions shows how a pathogen can alter host-cell control systems, rather than merely provoking inflammation, and helps explain progression from infection-associated changes toward cancer risk.
Immune evasion changes the outcome of exposure by reducing the likelihood that the host will clear the pathogen. For high-risk HPV types, this can create a prolonged infection state in which genotype-specific viral activity and host responses interact over time. The immunological importance lies in explaining why genetically distinct strains can produce different risks within the same host species.
Genotype identification separates infections associated with different levels of concern instead of treating all pathogen variants as equivalent. In HPV-related work, that information contributes to infection risk assessment and cervical cancer screening. It also helps investigators relate a detected genotype to persistence, tissue damage, or progression, while supporting consistent surveillance of pathogen variation across populations.
Vaccination strategies can use knowledge of high-risk genotypes to focus prevention priorities on variants linked to more serious outcomes. Screening programs likewise use genotype information to guide risk assessment rather than relying only on the presence of HPV. Together, these approaches connect molecular classification with prevention decisions and help direct attention to infections with greater potential public-health significance.
Epidemiological surveillance tracks where high-risk genotypes occur and how their distribution may relate to infection and disease patterns. Within immunology and infection, this provides population-level context for studying host immunity, pathogen variation, and outcomes. Surveillance findings can inform vaccination and screening priorities while revealing whether changes in genotype prevalence should alter prevention or research focus.